Soon-Jae Park
Fortune : 3 064 M $ au 31/07/2026
Fortune : 3 064 M $ au 31/07/2026
Soon-Jae Park is currently Chief Executive Officer & Director at Alto Bio Science and Chairman at Alteogen, Inc. Formerly, Dr. Park was Chief Executive Officer & Director at Altos Biologics Co., Ltd. and Vice Chairman & Co-Chief Operating Officer at BINEX Co., Ltd. Education includes doctorates from Massachusetts Institute of Technology (1988) and Purdue University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALTEOGEN INC. 26,42 % | 31/03/2026 | 14 159 275 ( 26,42 % ) | 3 064 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALTEOGEN INC. | Président | 13/05/2008 |
Alto Bio Science | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
Altos Biologics Co., Ltd.
Altos Biologics Co., Ltd. BiotechnologyHealth Technology Develops bio similar macular degeneration treatment products | Directeur Général | - |
| BINEX CO., LTD. | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BINEX Co., Ltd.
BINEX Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Alteogen, Inc.
Alteogen, Inc. BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
Alto Bio Science | |
Altos Biologics Co., Ltd.
Altos Biologics Co., Ltd. BiotechnologyHealth Technology Develops bio similar macular degeneration treatment products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national